Washington University unveils 'GPS' cancer gene sequencing panel

November 22, 2011

November 22, 2011 | Genomics and Pathology Services at Washington University School of Medicine in St. Louis (GPS@WUSTL) is offering a new sequencing test for mutations in 28 cancer-associated genes. The genes in the test affect a variety of different types of tumors, including blood, lymph, lung, brain, bladder, kidney, skin, stomach, prostate and breast cancers. Physicians throughout the U.S. can order the new test to simultaneously examine the genes most likely to influence treatment of a patient’s tumor. Washington University in St Louis